DE3867403D1 - L-dopa-derivate oder ihre saeureadditionssalze, verfahren zu ihrer herstellung und ihre verwendung. - Google Patents
L-dopa-derivate oder ihre saeureadditionssalze, verfahren zu ihrer herstellung und ihre verwendung.Info
- Publication number
- DE3867403D1 DE3867403D1 DE8888115183T DE3867403T DE3867403D1 DE 3867403 D1 DE3867403 D1 DE 3867403D1 DE 8888115183 T DE8888115183 T DE 8888115183T DE 3867403 T DE3867403 T DE 3867403T DE 3867403 D1 DE3867403 D1 DE 3867403D1
- Authority
- DE
- Germany
- Prior art keywords
- optionally substituted
- acid addition
- denotes
- production
- addition salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/16—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP23429987 | 1987-09-18 | ||
JP3126088 | 1988-02-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3867403D1 true DE3867403D1 (de) | 1992-02-13 |
Family
ID=26369718
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8888115183T Expired - Lifetime DE3867403D1 (de) | 1987-09-18 | 1988-09-16 | L-dopa-derivate oder ihre saeureadditionssalze, verfahren zu ihrer herstellung und ihre verwendung. |
Country Status (12)
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003070245A1 (en) * | 2002-02-15 | 2003-08-28 | Darpharma, Inc. | Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists |
WO2004052841A1 (en) * | 2002-12-06 | 2004-06-24 | Xenoport, Inc. | Carbidopa prodrugs and uses thereof |
US6970629B2 (en) | 2002-12-19 | 2005-11-29 | Corning Cable Systems Llc | Optical tube assembly having a dry insert and methods of making the same |
US7471862B2 (en) | 2002-12-19 | 2008-12-30 | Corning Cable Systems, Llc | Dry fiber optic cables and assemblies |
US20090190890A1 (en) | 2002-12-19 | 2009-07-30 | Freeland Riley S | Fiber optic cable having a dry insert and methods of making the same |
IL154318A (en) | 2003-02-06 | 2010-05-31 | Sarah Herzog Memorial Hospital | Pharmaceutical compositions for the treatment of movement disorders |
KR101287297B1 (ko) | 2004-06-04 | 2013-07-23 | 제노포트 인코포레이티드 | 레보도파 프로드러그, 및 그의 조성물 및 용도 |
US7323585B2 (en) * | 2004-06-04 | 2008-01-29 | Xenoport, Inc. | Levodopa prodrugs, and compositions and uses thereof |
AU2006322051B2 (en) * | 2005-12-05 | 2011-09-29 | Xenoport, Inc. | Levodopa prodrug mesylate, compositions thereof, and uses thereof |
CA2673336A1 (en) | 2006-12-21 | 2008-06-26 | Xenoport, Inc. | Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of use |
US7829592B2 (en) | 2006-12-21 | 2010-11-09 | Xenoport, Inc. | Catechol protected levodopa diester prodrugs, compositions, and methods of use |
US8399513B2 (en) | 2008-10-20 | 2013-03-19 | Xenoport, Inc. | Levodopa prodrug mesylate hydrate |
CN102186804A (zh) | 2008-10-20 | 2011-09-14 | 克塞诺波特公司 | 合成左旋多巴酯前药的方法 |
KR101025612B1 (ko) * | 2008-11-10 | 2011-03-30 | 한국해양연구원 | 신규 화합물인 Ramalin 및 그 용도 |
JP2013520521A (ja) | 2009-11-09 | 2013-06-06 | ゼノポート,インコーポレーテッド | レボドパプロドラッグの医薬組成物及び経口剤形並びに使用方法 |
ES2614179T3 (es) | 2010-03-04 | 2017-05-30 | Orion Corporation | Uso de levodopa, carbidopa y entacapona para el tratamiento de la enfermedad de Parkinson |
CN103694127B (zh) * | 2013-12-30 | 2015-04-01 | 上海交通大学 | 链霉菌属菌种所产的化合物及该化合物的制备方法和应用 |
SG11201703170RA (en) | 2014-10-21 | 2017-05-30 | Abbvie Inc | Carbidopa and l-dopa prodrugs and their use to treat parkinson's disease |
KR20180004756A (ko) | 2015-05-06 | 2018-01-12 | 신애질 코포레이션 | 약물 입자를 함유하는 제약 현탁액, 그의 투여를 위한 장치, 및 그의 사용 방법 |
WO2019097120A1 (en) | 2017-11-16 | 2019-05-23 | Orion Corporation | New use and pharmaceutical dosage forms |
BR112021009353A2 (pt) | 2018-11-15 | 2021-11-23 | Abbvie Inc | Formulações farmacêuticas para administração subcutânea |
US20220213128A1 (en) * | 2021-01-03 | 2022-07-07 | RockGen Therapeutics LLC | L-Dopa Enhanced with a Neuroprotective Agent as a Therapy for Parkinson's Disease |
US20240415800A1 (en) * | 2021-10-11 | 2024-12-19 | The Johns Hopkins University | Dopa and caffeic acid analogs as novel gcpii inhibitors |
WO2025075499A1 (en) | 2023-10-02 | 2025-04-10 | Universiteit Van Amsterdam | Reducing dopamine feed-back inhibition in dopaminergic cells by tadalafil. |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US393923A (en) * | 1888-12-04 | Samuel preston | ||
US2868818A (en) * | 1953-12-15 | 1959-01-13 | Merck & Co Inc | Alpha methyl phenylalanines |
US3725470A (en) * | 1969-05-14 | 1973-04-03 | Hoffmann La Roche | Amino acid derivatives |
CH562199A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1970-10-30 | 1975-05-30 | Hoffmann La Roche | |
BE793426A (fr) * | 1971-12-28 | 1973-06-28 | Lannacher Heilmittel G M B H | Derives de phenylalanine |
US3983138A (en) * | 1973-09-25 | 1976-09-28 | Merck & Co., Inc. | Amino acid esters |
US3891696A (en) * | 1973-11-02 | 1975-06-24 | Interx Research Corp | Novel, transient pro-drug forms of l-dopa |
US3939253A (en) * | 1973-11-02 | 1976-02-17 | Interx Research Corporation | Novel, transient pro-drug forms of l-dopa useful in the treatment of parkinson's disease |
US4401676A (en) * | 1977-06-01 | 1983-08-30 | Merck & Co., Inc. | Novel α-amino acids |
US4311706A (en) * | 1980-01-22 | 1982-01-19 | Interx Research Corporation | Novel dopa/dopamine prodrugs |
-
1988
- 1988-09-10 JP JP63227086A patent/JPH02138A/ja active Granted
- 1988-09-14 CA CA000577320A patent/CA1316180C/en not_active Expired - Fee Related
- 1988-09-15 IL IL87765A patent/IL87765A0/xx unknown
- 1988-09-16 EP EP88115183A patent/EP0309827B1/en not_active Expired - Lifetime
- 1988-09-16 PT PT88526A patent/PT88526B/pt not_active IP Right Cessation
- 1988-09-16 KR KR1019880012032A patent/KR890005031A/ko not_active Withdrawn
- 1988-09-16 DE DE8888115183T patent/DE3867403D1/de not_active Expired - Lifetime
- 1988-09-16 AU AU22340/88A patent/AU2234088A/en not_active Abandoned
- 1988-09-16 DK DK517588A patent/DK517588A/da not_active Application Discontinuation
- 1988-09-16 AT AT88115183T patent/ATE71083T1/de active
- 1988-09-16 US US07/245,348 patent/US4966915A/en not_active Expired - Fee Related
- 1988-09-17 CN CN88107165A patent/CN1032785A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
JPH0541626B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1993-06-24 |
IL87765A0 (en) | 1989-02-28 |
EP0309827A1 (en) | 1989-04-05 |
DK517588A (da) | 1989-03-19 |
CA1316180C (en) | 1993-04-13 |
DK517588D0 (da) | 1988-09-16 |
EP0309827B1 (en) | 1992-01-02 |
PT88526A (pt) | 1988-10-01 |
JPH02138A (ja) | 1990-01-05 |
KR890005031A (ko) | 1989-05-11 |
US4966915A (en) | 1990-10-30 |
ATE71083T1 (de) | 1992-01-15 |
AU2234088A (en) | 1989-03-23 |
PT88526B (pt) | 1992-11-30 |
CN1032785A (zh) | 1989-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3867403D1 (de) | L-dopa-derivate oder ihre saeureadditionssalze, verfahren zu ihrer herstellung und ihre verwendung. | |
DE3850306D1 (de) | Camptothecin-Derivate und Verfahren zu ihrer Herstellung. | |
DE69100079D1 (de) | Naphthalin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
ATE268752T1 (de) | Aralkyl-1,2-diaminen mit calcimimetischer wirkung und verfahren zu ihrer herstellung | |
ATE52498T1 (de) | Amidderivate. | |
DK616388D0 (da) | Quinolincarboxylsyre-derivater og fysiologisk acceptable salte deraf med antibakteriel virkning | |
SE7614678L (sv) | Sett att framstella nya oximderivat av 7-aminotiazolyl-acetamido-cefalosporansyraderivat | |
ATE122042T1 (de) | Pyrazoloisoquinoline-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. | |
ATE79257T1 (de) | Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden. | |
ATE92489T1 (de) | Imid-derivate, ihre herstellung und verwendung. | |
DE3864707D1 (de) | Benzoxazin-derivate und verfahren zu ihrer herstellung. | |
ATE159029T1 (de) | Phosphonsäurederivate, verfahren zur herstellung und ihre verwendung | |
DE69017855D1 (de) | Oxetan-Derivate, ihre Herstellung und ihre Verwendung als Anti-Fungal oder fungizides Mittel. | |
ATE8045T1 (de) | Azolylalkyl-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide. | |
ATE10273T1 (de) | Aminopropanol-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide. | |
DE3762969D1 (de) | Piperazinverbindungen, verfahren zu ihrer herstellung, pharmazeutische zusammensetzung und verwendung. | |
ATE69448T1 (de) | Chinolincarbonsaeure-derivate, diese enthaltende zusammensetzung, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von medikamenten. | |
DE69119714D1 (de) | Verfahren zur Herstellung von Benzylphthalazinonderivaten und von deren Salzen | |
ATE18763T1 (de) | Diazolyl-alkanole, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel. | |
NO20022290L (no) | Aryloksypropanolaminer for forbedring av husdyravl | |
ATE87920T1 (de) | Keten-s,s,-acetalderivate, verfahren zu ihrer herstellung und methode zur heilung von mykose unter verwendung dieser derivate. | |
HUT43586A (en) | Process for production of derivatives and salts of 8-tiotetrahydro-quinoline and medical preparatives containing thereof as active substance | |
DE3884518D1 (de) | Naphthothiazepin-derivate und verfahren zu ihrer herstellung. | |
PT75981A (en) | Process for the preparation of n,n-dissubstituted alkenamides and phenyl alkenamides | |
HUT62269A (en) | Process for producing new 1,2,3,6-tetrahydropyridine derivatives and compositions comprising same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |